Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Though not yet widespread among GLP-1 manufacturers, this advanced methodology could transform the industry in the near future
This provides the medium-term view of glucose control that spot fasting glucose measurements can miss
This novel single-peptide triagonist, developed by Eli Lilly and Company, simultaneously activates three distinct receptor systems that regulate energy balance, glucose metabolism, and body weight
DCF Considerations for Commercial-Stage Assets For a drug already generating revenue, a standard DCF model supplements the rNPV approach
Crowley MJ, McGuire DK, Alexopoulos AS, et al
Insulinotropin: Glucagon-Like Peptide I (7-37) Co-Encoded in the Glucagon Gene Is a Potent Stimulator of Insulin Release in the Perfused Rat Pancreas
US$ 26.20
US$ 22.89
00197-4/asset/bc822c6e-5915-4cb3-97bc-7187c857a496/main.assets/gr1_lrg.jpg)
US$ 27.39
02105-1/asset/8468e457-0c7f-4e4c-9b6d-2202dbefa9cb/main.assets/gr1_lrg.jpg)
US$ 27.36
US$ 27.24
US$ 28.87
US$ 25.36
US$ 28.82
US$ 29.17
